Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.50
-0.10 (-0.74%)
Sep 11, 2026, 3:18 PM HKT

HKG:2480 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-133.07-150.58-200.67-260.3-180.39-112.24
Net Income
-134.41-150.36-168.24-249.35-725.18-539.36
Earnings Per Share
-0.68-0.75-0.83-1.25-4.98-5.94
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
367.59419.46453.68608.33581.64564.4
Total Debt
313.5627367.5319.2211.221,248
Net Cash (Debt)
54.03146.47386.15589.11570.42-683.7
Net Cash Growth
-63.11%-62.07%-34.45%3.28%--
Net Cash Per Share
0.270.731.912.963.92-7.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-99.37-129.05-86.09-189.95-77.27-19.17
Capital Expenditures
-48.5-60.13-94.37-85.78-208.21-59.92
Free Cash Flow
-147.87-189.17-180.45-275.72-285.47-79.08
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.